Enticed by tax reform, Pfizer ups dividend, marks $10B for buybacks. Who's next?admin 19th December 2017 Uncategorised 0
President Donald Trump has long trumpeted the idea that slashing the corporate tax rate would spur job growth. But if Pfizer is any indication, hiring is likely fairly low down on the priority list for Big Pharma.
More: Enticed by tax reform, Pfizer ups dividend, marks B for buybacks. Who's next?